KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Liabilities and Shareholders Equity (2016 - 2025)

Humana (HUM) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $48.9 billion as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity changed N/A to $48.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $199.9 billion, a N/A change, with the full-year FY2025 number at $48.9 billion, changed N/A from a year prior.
  • Liabilities and Shareholders Equity was $48.9 billion for Q4 2025 at Humana, down from $49.7 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $56.5 billion in Q2 2023 to a low of $37.4 billion in Q1 2021.
  • A 4-year average of $47.9 billion and a median of $48.9 billion in 2025 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: rose 26.85% in 2021, then fell 2.94% in 2022.
  • Humana's Liabilities and Shareholders Equity stood at $44.4 billion in 2021, then dropped by 2.94% to $43.1 billion in 2022, then grew by 29.85% to $55.9 billion in 2023, then dropped by 12.51% to $48.9 billion in 2025.
  • Per Business Quant, the three most recent readings for HUM's Liabilities and Shareholders Equity are $48.9 billion (Q4 2025), $49.7 billion (Q3 2025), and $50.4 billion (Q2 2025).